Pioneered by Associate Professor Leo Hwa Liang from the Department of Biomedical Engineering at NUS» Faculty of Engineering, and Dr Jimmy Hon from the Department of Surgery at the NUS Yong Loo Lin School of Medicine, this novel invention addresses a clinical gap in the current treatment
of mitral valve regurgitation.
After going through a medical test at the national Cardiothoracic centre at the Korle - Bu Teaching Hospital, the report indicated that he was suffering from rheumatic heart disease with severe aortic valve incompetence and mild to
moderate mitral valve regurgitation.
Thirty patients with a condition
called mitral valve regurgitation (MR) were treated with the device at six clinical centers in Europe, sponsored by the manufacturer of the device, Harpoon Medical, Inc., Baltimore, Md., to determine whether the device meets essential European health and safety requirements.
Underlying conditions such as bronchitis, bronchopneumonia,
mitral valve regurgitation, obesity and hyperadrenocorticism may exacerbate signs of tracheal collapse and should be managed accordingly.
For obtaining RF PISA, the color flow Doppler jet of
mitral valve regurgitation was first identified with optimal gain setting.